Home › Crohn's Disease › Kentucky › Lexington
Crohn's Disease clinical trials in Lexington, KY
3 studies for Crohn's Disease are looking for participants at sites in and around Lexington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- University of Kentucky/Markey Cancer Center, Lexington
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RecruitingPhase 2
- University of Kentucky Chandler Medical Center /ID# 265564, Lexington
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- University of Kentucky Hospital/UK Albert B. Chandler Hospital-Site Number: 8400058, Lexington
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY35 studies
- Boston, MA19 studies
- Miami, FL19 studies
- Cleveland, OH19 studies
- St. Louis, MO19 studies
- Tyler, TX17 studies
- Orlando, FL17 studies
- Houston, TX17 studies
- Atlanta, GA17 studies
- San Antonio, TX15 studies
- Los Angeles, CA15 studies
- San Diego, CA15 studies
Other studies in Lexington
- Non-Small Cell Lung Cancer23 studies
- Lung Cancer18 studies
- Ovarian Cancer16 studies
- Prostate Cancer14 studies
- Cancer (all types)14 studies
- Breast Cancer14 studies
- Metastatic Cancer11 studies
- Colorectal Cancer11 studies
- Heart Failure11 studies
- Melanoma10 studies
- Acute Myeloid Leukemia10 studies
- Obesity10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.